Search

Search Constraints

You searched for: Author/Creator Zektser, Miri

Search Results

1. Characteristics and outcome of multiple myeloma patients presenting with anaemia only: A retrospective multi-centre study. (February 2021)

2. Daratumumab for relapsed AL amyloidosis—When cumulative real‐world data precedes clinical trials: A multisite study and systematic literature review. (9th November 2020)

3. Daratumumab for relapsed AL amyloidosis—When cumulative real‐world data precedes clinical trials: A multisite study and systematic literature review. (9th November 2020)

4. Outcome of relapsed/refractory diffuse large B-cell lymphoma patients treated with polatuzumab vedotin-based therapy: real-life experience. Issue 1 (2nd January 2021)

5. Real‐world experience with belantamab mafodotin therapy for relapsed/refractory multiple myeloma: A multicentre retrospective study. (7th October 2022)

6. Venetoclax combinations induce high response rates in newly diagnosed acute myeloid leukemia patients ineligible for intensive chemotherapy in routine practice. Issue 7 (29th April 2021)

7. Venetoclax is safe and efficacious in relapsed/refractory AML. Issue 9 (28th July 2020)

8. Willingness and concerns of transfusion-dependent hematological patients toward the option of home transfusion therapy. (May 2021)